The Air Force has not found a higher death rate from cancer among missileers and other service members who served decades ago near America’s nuclear-tipped intercontinental ballistic missiles, service officials said Jan. 30.
Based on an updated and expanded data set, the Air Force now says the preliminary statistics show no significant difference in cancer rates between Airmen who worked on nuclear intercontinental ballistic missiles and the rest of the Air Force or the general population.
The Air Force found increased rates of breast and prostate cancers in service members who worked on nuclear intercontinental ballistic missiles compared to the general population, according to a preliminary study of data publicly released on March 13. “What we don’t know is whether these ...
The Air Force’s study into possible cancer risks associated with work on intercontinental ballistic missiles will be a comprehensive review—and will not favor the service over evidence, medical officials leading the effort insisted. “We need our solutions to be driven by science and data,” Col. ...
The Air Force is pressing to find out why some Airmen and former Airmen who worked wth the nation's intercontinental continental ballistic missile fleet are being diagnosed with blood cancer—years after the service dismissed such concerns in the early 2000s.
The Air Force authorized telework for most Pentagon-based personnel, canceled all outreach activities and events through May 15, put a hold on most official travel, and sent cadets home from the U.S. Air Force Academy in Colorado Springs, Colo., in response to the COVID-19 outbreak. ...